Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Y Lin

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2018
BET bromodomain proteins regulate enhancer function during adipogenesisJonathan D Brown, Zachary B Feldman, Sean P Doherty, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Nature Communications|August 22, 2019
PAX8 activates metabolic genes via enhancer elements in Renal Cell CarcinomaMelusine Bleu, Swann Gaulis, Rui Lopes, et al.
Cancer Cell|December 17, 2013
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphomaBjoern Chapuy, Michael R McKeown, Charles Y Lin, et al.
Nature Communications|July 27, 2022
Targeting transcription in heart failure via CDK7/12/13 inhibitionAustin Hsu, Qiming Duan, Daniel S Day, et al.
Cell Chemical Biology|March 26, 2019
Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeCalla M Olson, Yanke Liang, Alan Leggett, et al.
Genome Biology|January 28, 2016
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancerHolger Heyn, Enrique Vidal, Humberto J Ferreira, et al.
Blood Advances|September 20, 2021
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependencyMonika W Perez, Oscar Sias-Garcia, Alfred Daramola, et al.
Blood|March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myelomaYao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.
Cell Reports. Medicine|February 1, 2021
Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identityHadley E Sheppard, Alessandra Dall'Agnese, Woojun D Park, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2018
BET bromodomain proteins regulate enhancer function during adipogenesisJonathan D Brown, Zachary B Feldman, Sean P Doherty, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Nature Communications|August 22, 2019
PAX8 activates metabolic genes via enhancer elements in Renal Cell CarcinomaMelusine Bleu, Swann Gaulis, Rui Lopes, et al.
Cancer Cell|December 17, 2013
Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphomaBjoern Chapuy, Michael R McKeown, Charles Y Lin, et al.
Nature Communications|July 27, 2022
Targeting transcription in heart failure via CDK7/12/13 inhibitionAustin Hsu, Qiming Duan, Daniel S Day, et al.
Cell Chemical Biology|March 26, 2019
Development of a Selective CDK7 Covalent Inhibitor Reveals Predominant Cell-Cycle PhenotypeCalla M Olson, Yanke Liang, Alan Leggett, et al.
Genome Biology|January 28, 2016
Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancerHolger Heyn, Enrique Vidal, Humberto J Ferreira, et al.
Blood Advances|September 20, 2021
Defining the transcriptional control of pediatric AML highlights RARA as a superenhancer-regulated druggable dependencyMonika W Perez, Oscar Sias-Garcia, Alfred Daramola, et al.
Blood|March 6, 2023
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myelomaYao Yao, Jessica Fong Ng, Woojun Daniel Park, et al.
Cell Reports. Medicine|February 1, 2021
Targeted brachyury degradation disrupts a highly specific autoregulatory program controlling chordoma cell identityHadley E Sheppard, Alessandra Dall'Agnese, Woojun D Park, et al.
Pageof 9